Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wynn Macau, Limited Director's Dealing 2022

Sep 2, 2022

49711_rns_2022-09-02_da848dcb-8b9f-43a6-b549-f3c39beacdc4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [260 x 95] intentionally omitted <==

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 1128 and Debt Stock Codes: 5279, 5280, 40102, 40259, 40357)

GRANT OF OPTIONS

Pursuant to Rule 17.06A of The Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”), the board (the “ Board ”) of directors (the “ Directors ”) of Wynn Macau, Limited (the “ Company ”) hereby announces that on 2 September 2022, the Company granted 4,784,000 options (the “ Options ”) to the five independent nonexecutive Directors (the “ Grantees ”) to subscribe for an aggregate of 4,784,000 ordinary shares of HK$0.001 each in the capital of the Company (the “ Shares ”) under the share option scheme (the “ Scheme ”) adopted by the Company on 30 May 2019, subject to acceptance by the Grantees.

Details of the Options granted are as follows:

Date of Grant : 2 September 2022 (the “ Date of Grant ”) Subscription price per Share : HK$4.71 under the Options Closing price per Share on : HK$4.70 the Date of Grant Average closing price per : HK$4.71 Share for the five business days preceding the Date of Grant Exercise period (subject to : 2 September 2023 to 1 September 2032, both dates inclusive. the vesting of the Options)

  • For identification purposes only

1

Vesting Schedule

  • : The Options may be exercised starting from the first anniversary of the Date of Grant as follows:

    • Year 1: up to 20% of the Shares comprised in the Options at the Date of Grant as subsequently adjusted in accordance with the Scheme, if applicable;

    • Year 2: up to 40% of the Shares so comprised, less the percentage of Shares in respect of which the Options were exercised in Year 1;

    • Year 3: up to 60% of the Shares so comprised, less the percentage of Shares in respect of which the Options were exercised in Years 1 and 2;

    • Year 4: up to 80% of the Shares so comprised, less the percentage of Shares in respect of which the Options were exercised in Years 1, 2 and 3; and

    • Year 5: all Shares so comprised in respect of which the Options were not previously exercised.

Grantees:NameIndependent non-executive DirectorsAllan ZemanBruce RockowitzLam Kin Fung JeffreyNicholas Sallnow-SmithLeah Dawn Xiaowei YeTotal: Number of Shares1,340,000861,000861,000861,000861,000
4,784,000

2

The grant of Options to the above Directors has been approved by the independent non-executive Directors (excluding the interested independent non-executive Director with respect to the Options which he/she has been granted) in accordance with the Listing Rules and the rules governing the Scheme. Save as disclosed herein, the Grantees are neither a director, chief executive nor substantial shareholder of the Company nor associates (as defined in the Listing Rules) of any of them.

By order of the Board Wynn Macau, Limited Dr. Allan Zeman Chairman

Hong Kong, 2 September 2022

As at the date of this announcement, the Board comprises Craig S. Billings, Ian Michael Coughlan and Frederic Jean-Luc Luvisutto (as Executive Directors); Linda Chen (as Executive Director and Vice Chairman); Matthew O. Maddox (as Non-Executive Director); Allan Zeman (as Independent Non-Executive Director and Chairman); and Lam Kin Fung Jeffrey, Bruce Rockowitz, Nicholas Sallnow-Smith and Leah Dawn Xiaowei Ye (as Independent Non-Executive Directors).

3